Live attenuated vaccine · VDDBV0267
Note: 4 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT00240877 | Phase 3 | Influenza |
| NCT00192179 | Phase 2 | Influenza |
| NCT00192413 | Phase 3 | Influenza |
| NCT00192231 | Phase 3 | Influenza |
| NCT00217230 | Phase 3 | Influenza |
| NCT00192192 | Phase 3 | Influenza |
| NCT00192361 | Phase 3 | Influenza |
| NCT00192166 | Phase 2 | Influenza |
| NCT00192426 | Phase 3 | Influenza |
| NCT03884296 | Approved | Influenza |
| NCT00385281 | Approved | Influenza |
| NCT00192218 | Approved | Influenza |
| NCT01938170 | — | Influenza |
| NCT00192140 | Approved | Influenza |
| NCT00138281 | Approved | Influenza |
| NCT00138385 | Approved | Influenza |
| NCT00231907 | Phase 1 | Influenza |
| NCT00192127 | Phase 3 | Influenza |
| NCT00192491 | Phase 3 | Influenza |
| NCT03023683 | Approved | Influenza |
| NCT01933048 | Approved | Influenza |
| NCT04164212 | Approved | Influenza |
| NCT00128167 | Phase 3 | Influenza |
| NCT03982069 | Approved | Influenza |
| NCT03143101 | Approved | Influenza |
| NCT00192322 | Phase 2 | Influenza |
| NCT00192153 | Phase 2 | Influenza |
| NCT00192387 | Phase 2 | Influenza |
| NCT00192283 | Phase 3 | Influenza |
| NCT00111579 | Phase 2 | Influenza |
| NCT00192309 | Phase 2 | Influenza |
| NCT01044095 | — | Influenza |
| NCT03088904 | Phase 1 | Influenza |
| NCT00001127 | Phase 3 | Influenza |
| NCT02597647 | Phase 1 | Influenza |
| NCT03898986 | Approved | Influenza |
| NCT03020472 | Approved | Influenza |